RareCyte Closes $22M Financing for Global Commercialization and Platform Expansion into Tissue Multiplexing
- Thursday, December 19, 2019, 7:24
- PR Newswire
- Add a comment
SEATTLE, Dec. 19, 2019 /PRNewswire/ — RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company creating liquid and tissue biopsy analysis platforms with emphasis on rare cell detection announced today the completion of a $22M financing from new and existing investors. The…
About the Author
admin has written 21643 stories on this site.